secwatch.observer — SEC 8-K summary
======================================

Issuer:     VYNE Therapeutics Inc. (VYNE)
CIK:        0001566044
Form:       8-K
Filed at:   2022-05-17T23:59:59+00:00
Accession:  0001104659-22-061796
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VYNE hosts KOL event to update on BET inhibitor platform and VYN201
-------------------------------------------------------------------

- Virtual KOL event held May 17, 2022 on InhiBET platform and VYN201.
- Presentation attached as Exhibit 99.1 and available on company website.
- No specific clinical data or financial results disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1566044/000110465922061796/0001104659-22-061796-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1566044/000110465922061796/tm2215701d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-061796

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer